Should one be able to patent a gene? An update.

So the Supreme Court listened to oral arguments from both parties in the case of Association for Molecular Pathology v. Myriad Genetics earlier today. While we will not know how the court decides to rule until some time in June this year, there is already an interesting analysis of the reactions of the justices to the oral arguments on the (relatively impartial) SCOTUS blog web site. … READ MORE …

Can a company patent a human gene? The showdown comes on Monday!

Next Monday, after conflicting rulings in other courts over the past 4 years, the case of Association for Molecular Pathology v. Myriad Genetics will be fought out before the Supreme Court of the United States (SCOTUS). At stake is the complex issue of exactly what is patentable related to the isolation and use of portions of the human genome (and other, related issues). … READ MORE …

Should it be possible to patent specific genes?

As we have previously discussed, the question posed above is a highly controversial one, and there is a legal case in the U.S. — the case challenging Myriad Genetics ownership of patents on the BRCA1 and BRCA2 genes for specific types of breast cancer — which has now reached the Supreme Court (sometimes called SCOTUS by Washington insiders). … READ MORE …